Find your next paid study

Memorial Sloan Kettering Cancer CenterNCT07313852

~$150 – $3,000

Actual pay is set by the research site.

Alzheimer Disease (AD)Mild Cognitive Impairment (MCI)

Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Disease

Alzheimer's Disease (AD) is associated with impairments in both gait and cognition, significantly increasing fall risk. Falls are a leading cause of injury-rel…

Boston University Charles River CampusNCT07659964

~$10 – $750

Actual pay is set by the research site.

Phase 2

A Pragmatic Randomized Phase II Trial Evaluating Total Ablative Therapy for Patients With Limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)

This phase III trial compares the addition of total ablative therapy to the usual systemic therapy versus the usual systemic therapy alone in treating patients…

Metastatic Colorectal AdenocarcinomaStage IV Colorectal Cancer AJCC v8Oligometastatic Colorectal Carcinoma

Alliance for Clinical Trials in OncologyNCT05673148

~$75 – $2,000

Actual pay is set by the research site.

Biochemically Recurrent Prostate CarcinomaProstate Adenocarcinoma

ENLIGHTEN: Detection by POSLUMA Following Negative Other PET-PSMA Imaging

This phase II trial evaluates an imaging technique (rhPSMA-7.3 positron emission tomography \[PET\]/computed tomography \[CT\]) for detecting prostate cancer i…

Northwestern UniversityNCT06813898

~$150 – $3,000

Actual pay is set by the research site.

Bladder CancerSquamous Cell Carcinoma of the LungEsophageal Squamous Cell Carcinoma+8 more

A Phase 1 Dose-Escalation and Expansion Study Evaluating the Safety, Efficacy, and Pharmacokinetics of EVOLVE104 in Subjects With Advanced Urothelial and Squamous Cell Carcinomas

The goal of this study is to evaluate the safety and effectiveness of EVOLVE104 in participants with advanced urothelial and squamous cell carcinomas who have …

~$150 – $4,200

Actual pay is set by the research site.

EvolveImmune United, Inc

Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations

The PI and the research team developed the New York University (NYU) Electronic Patient Visit Assessment (ePVA) for head and neck cancer (HNC) as a patient-rep…

Head and Neck Cancer

The University of Texas Health Science Center, HoustonNCT06030011

~$10 – $750

Actual pay is set by the research site.

B-Cell Non-Hodgkin's Lymphoma (NHL)Lymphoma, Non-HodgkinsLymphomas Non-Hodgkin's B-Cell+12 more

An Open-Label, Dose Escalation, Multi-Center Phase I/II Clinical Trial of EB103 T-Cell Therapy in Adults With Relapsed/Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (NHL)

This is an open-label, multi-center, Phase 1/2 clinical trial evaluating the safety and effectiveness of EB103 in R/R B-cell NHL patients with the highest unme…

~$150 – $4,200

Actual pay is set by the research site.

TBI (Traumatic Brain Injury)HeadacheDepression

Combined Nonpharmacological Therapies for MTBI-Related Headaches

This study will assess the combined effectiveness of repetitive transcranial magnetic stimulation (rTMS) and telehealth based therapy in helping manage mild tr…

Veterans Medical Research FoundationNCT05176392

~$10 – $675

Actual pay is set by the research site.

Advanced Malignant Solid NeoplasmHematopoietic and Lymphatic System Neoplasm

Community-Engaged Pilot Testing of Talking About Cancer (TAC) to Improve Engagement in Advance Care Planning

This clinical trial studies whether telephone-based coaching sessions, Talking About Cancer (TAC), work to improve engagement in advance care planning (ACP) in…

Fred Hutchinson Cancer CenterNCT07141407

~$10 – $750

Actual pay is set by the research site.

Phase 2

A Window Trial of 5-Azacytidine or Nivolumab or Combination Nivolumab Plus 5-Azacytidine in Resectable HPV-Associated Head and Neck Squamous Cell Cancer

This study is being done because both 5-azacytidine and nivolumab can influence the immune system's response to HPV-associated head and neck cancer, and we wis…

Squamous Cell Carcinoma of Head and Neck

Barbara BurtnessNCT05317000

~$75 – $3,000

Actual pay is set by the research site.

Phase 2

Phase II Trial Evaluating Trastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic Breast Cancer (MBC)

The purpose of this study is to evaluate use of lovastatin, a drug that may lower CAV-1 levels, in order to increase HER2 expression on cells and enhance the u…

Breast CancerAdvanced Breast CancerMetastatic Breast Cancer

Washington University School of MedicineNCT07619365

~$75 – $2,000

Actual pay is set by the research site.

High-Grade Anal Intraepithelial Neoplasia

A Phase I Study of Intra-anally Administered Lopinavir/Ritonavir in People Living With HIV (PLWH) With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3)

This study is being done to assess the safety of lopinavir/ritonavir in patients with PLWH with AIN. 30 participants will be recruited and can expect to be on …